Seaweed-Derived Halogenated Monoterpenes as Lead Compounds in Schistosomiasis Control
Pharmaceutics · 23.06.2026 · 18 (7) · 767
DOI: 10.3390/pharmaceutics18070767 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 23.06.2026. Verfasst von Sara Guibunda Tajú und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Center in Biodiversity and Conservation-CPBC, Púnguè University, Chimoio 333, Manica, Mozambique. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FAPESP.
Abstract (Originalsprache)
Background/Objectives: Schistosomiasis, a parasitic disease caused by Schistosoma worms with freshwater snails as intermediate hosts, affects over 250 million people. The current control relies solely on praziquantel, which raises concerns on drug resistance and highlights the need for new therapeutic alternatives. Our bioprospection studies have focused on marine macroalgae as an unexplored source of antischistosomal metabolites with promising results. Guided by WHO recommendations to target both the parasite and its transmission vectors, this study aimed to investigate Ochtodes secundiramea to: (i) isolate active metabolites; (ii) evaluate the isolated compounds against adult worms and oviposition to identify leads for drug development; and (iii) perform an independent screening of their effects against the environmental transmission stages on cercariae and B. glabrata embryos.
Methods
A dichloromethane extract of O. secundiramea was submitted to an NMR–biomonitored guided fractionation against Schistosoma mansoni adult worms. Active fractions were further purified through HPLC and characterized by 1H and 13C NMR spectroscopy to identify the isolated compounds.
Results
Three halogenated monoterpenes were isolated: ochtodene 1 (4-bromo-1,6,8-trichloro-2,3-ochtodene), ochtodene 2 (2-chloro-1,6,8-tribromo-3,8-ochtodene), and the novel natural product ochtodene 3 [2,6-dibromo-4-(2-chloroethylidene)-1,1dimethylcyclohexane]. Ochtodene 1 was the primary active metabolite against Schistosoma mansoni adult worms, with IC50/96 h values of 47.2 and 46.1 µM for male and female worms respectively, and totally suppressed egg laying with 60 µM, while showing no toxicity toward human fibroblasts. Notably, all metabolites, including the novel ochtodene 3, caused 100% mortality in cercariae and embryos at low concentrations.
Conclusions
The discovery of the novel ochtodene 3 and the identification of distinct leads for host treatment and transmission elimination position O. secundiramea as a promising source for integrated schistosomiasis control.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Center in Biodiversity and Conservation-CPBC, Púnguè University, Chimoio 333, Manica, Mozambique.
- Laboratory of Parasitology, Butantan Institute, São Paulo 05503-900, Brazil.
- Laboratory of Algae Biochemistry and Molecular Biology, Institute of Chemistry, University of São Paulo, São Paulo 05508-090, Brazil.
ORCID-Profile: Sara Guibunda Tajú, Amanda Beatriz da Silva Soares, Patrícia Aoki Miyasato, Rafaela Paula de Freitas, Lenita de Freitas Tallarico, Erika Mattos Stein, Pio Colepicolo, Eliana Nakano
Förderung
- FAPESP
Zitieren
APA
Tajú, S. G., Soares, A. B. D. S., Miyasato, P. A., de Freitas, R. P., Tallarico, L. F., Stein, E. M., Colepicolo, P., & Nakano, E. (2026). Seaweed-Derived Halogenated Monoterpenes as Lead Compounds in Schistosomiasis Control. Pharmaceutics, 18(7), 767. https://doi.org/10.3390/pharmaceutics18070767
Vancouver
Tajú SG, Soares ABDS, Miyasato PA, de Freitas RP, Tallarico LF, Stein EM, et al. Seaweed-Derived Halogenated Monoterpenes as Lead Compounds in Schistosomiasis Control. Pharmaceutics. 2026;18(7):767. doi:10.3390/pharmaceutics18070767
BibTeX
@article{Taj2026,
author = {Tajú, Sara Guibunda and Soares, Amanda Beatriz da Silva and Miyasato, Patrícia Aoki and de Freitas, Rafaela Paula and Tallarico, Lenita de Freitas and Stein, Erika Mattos and Colepicolo, Pio and Nakano, Eliana},
title = {Seaweed-Derived Halogenated Monoterpenes as Lead Compounds in Schistosomiasis Control},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {7},
pages = {767},
doi = {10.3390/pharmaceutics18070767}
}
EUVIMED